Patents by Inventor Todd E. Rasmussen

Todd E. Rasmussen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10111669
    Abstract: A system for deploying and selectively inflating a thoracic aortic balloon at a desired location within the thoracic aorta for resuscitative aortic occlusion, inferior to the left subclavian artery, without the aid of fluoroscopy is described. Using CT imaging data, a distance between readily identifiable and consistently located external landmarks of torso extent is measured. Next, using the same data, a second distance from the femoral artery to a desired aortic occlusion location inferior to the left subclavian artery is determined. A correlation between the external measure of torso extent and the desired intra-arterial (i.e. endovascular) distance within the torso is made. Using a nomogram, a calibrated endovascular resuscitative thoracic aortic occlusion system can be positioned to this desired location on any injured individual with end-stage shock and impending cardiovascular collapse or death without the aid of fluoroscopy for delivery or balloon inflation.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: October 30, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jonathan L. Eliason, Todd E. Rasmussen
  • Publication number: 20160000446
    Abstract: A system for deploying and selectively inflating a thoracic aortic balloon at a desired location within the thoracic aorta for resuscitative aortic occlusion, inferior to the left subclavian artery, without the aid of fluoroscopy is described. Using CT imaging data, a distance between readily identifiable and consistently located external landmarks of torso extent is measured. Next, using the same data, a second distance from the femoral artery to a desired aortic occlusion location inferior to the left subclavian artery is determined. A correlation between the external measure of torso extent and the desired intra-arterial (i.e. endovascular) distance within the torso is made. Using a nomogram, a calibrated endovascular resuscitative thoracic aortic occlusion system can be positioned to this desired location on any injured individual with end-stage shock and impending cardiovascular collapse or death without the aid of fluoroscopy for delivery or balloon inflation.
    Type: Application
    Filed: September 14, 2015
    Publication date: January 7, 2016
    Inventors: Jonathan L. Eliason, Todd E. Rasmussen
  • Patent number: 9131874
    Abstract: A system for deploying and selectively inflating a thoracic aortic balloon at a desired location within the thoracic aorta for resuscitative aortic occlusion, inferior to the left subclavian artery, without the aid of fluoroscopy is described. Using CT imaging data, a distance between readily identifiable and consistently located external landmarks of torso extent is measured. Next, using the same data, a second distance from the femoral artery to a desired aortic occlusion location inferior to the left subclavian artery is determined. A correlation between the external measure of torso extent and the desired intra-arterial (i.e. endovascular) distance within the torso is made. Using a nomogram, a calibrated endovascular resuscitative thoracic aortic occlusion system can be positioned to this desired location on any injured individual with end-stage shock and impending cardiovascular collapse or death without the aid of fluoroscopy for delivery or balloon inflation.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: September 15, 2015
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, The United States of America as represented by the Secretary of the Air Force
    Inventors: Jonathan L. Eliason, Todd E. Rasmussen
  • Publication number: 20130102926
    Abstract: A system for deploying and selectively inflating a thoracic aortic balloon at a desired location within the thoracic aorta for resuscitative aortic occlusion, inferior to the left subclavian artery, without the aid of fluoroscopy is described. Using CT imaging data, a distance between readily identifiable and consistently located external landmarks of torso extent is measured. Next, using the same data, a second distance from the femoral artery to a desired aortic occlusion location inferior to the left subclavian artery is determined. A correlation between the external measure of torso extent and the desired intra-arterial (i.e. endovascular) distance within the torso is made. Using a nomogram, a calibrated endovascular resuscitative thoracic aortic occlusion system can be positioned to this desired location on any injured individual with end-stage shock and impending cardiovascular collapse or death without the aid of fluoroscopy for delivery or balloon inflation.
    Type: Application
    Filed: April 21, 2011
    Publication date: April 25, 2013
    Applicants: Government of the United States c/o Secretary of the Air Force, THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jonathan L. Eliason, Todd E. Rasmussen
  • Patent number: 8251943
    Abstract: A novel shunt comprises: a first lumen having a first end and a second end, wherein the first lumen is composed of a polydimethylsiloxane material; a bulb-shaped portion positioned on each of the first end and the second end; a reinforcing spring extending along the first lumen from the first end and the second end; and a second lumen having a first end and a second end, wherein the first end is connected to a center portion of the first lumen and the second end is connected to a valve.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: August 28, 2012
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Jerry R. Spencer, Todd E. Rasmussen, Shaun M. Gifford